FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294724274> ?p ?o ?g. }

• W4294724274 abstract "Purpose: To investigate the effectiveness of vocal therapy with the use of low-frequency transcutaneous electrical nerve stimulation (TENS) followed by voice exercises on vocal fold lesion size, vocal quality and quality of life in dysphonic women. Methods: 27 women with vocal nodules participated, randomized into to: experimental group (EG)—13 women who received vocal therapy with 12 sessions of 20 min of TENS application (pulse:200μs, frequency:10Hz, motor threshold intensity, electrodes positioned in the trapezius muscle [descending fibers and submandibular region, bilaterally]). Each TENS session was followed by 30 min of vocal exercises; and the Control Group (CG)- 14 women who received 12 sessions with 20 min of application of placebo TENS (same conditions EG, but without receiving the stimulus electric), followed by 30 min of vocal exercise. Before, immediately after and one month after vocal therapy, participants underwent vocal recording for acoustic analysis, vocal self-assessment, laryngological examination and answered voice-related quality of life (V-RQOL) protocol. Results: There was reduction in the size of vocal fold lesions only in the EG, immediately after treatment and one month after treatment. Acoustic analysis showed decreases in SPI values immediately after and one month after treatment in both groups. There was improvement in voice self-perception in both groups after treatment and one month after, but no significant difference in V-RQOL values. Conclusion: TENS followed by vocal exercises produced results similar to vocal therapy without TENS regarding voice quality, self-perception and quality of life in voice. However, vocal therapy with low-frequency TENS followed by vocal exercise was effective in reducing vocal fold lesion size in dysphonic women. Purpose: To investigate the effectiveness of vocal therapy with the use of low-frequency transcutaneous electrical nerve stimulation (TENS) followed by voice exercises on vocal fold lesion size, vocal quality and quality of life in dysphonic women. Methods: 27 women with vocal nodules participated, randomized into to: experimental group (EG)—13 women who received vocal therapy with 12 sessions of 20 min of TENS application (pulse:200μs, frequency:10Hz, motor threshold intensity, electrodes positioned in the trapezius muscle [descending fibers and submandibular region, bilaterally]). Each TENS session was followed by 30 min of vocal exercises; and the Control Group (CG)- 14 women who received 12 sessions with 20 min of application of placebo TENS (same conditions EG, but without receiving the stimulus electric), followed by 30 min of vocal exercise. Before, immediately after and one month after vocal therapy, participants underwent vocal recording for acoustic analysis, vocal self-assessment, laryngological examination and answered voice-related quality of life (V-RQOL) protocol. Results: There was reduction in the size of vocal fold lesions only in the EG, immediately after treatment and one month after treatment. Acoustic analysis showed decreases in SPI values immediately after and one month after treatment in both groups. There was improvement in voice self-perception in both groups after treatment and one month after, but no significant difference in V-RQOL values. Conclusion: TENS followed by vocal exercises produced results similar to vocal therapy without TENS regarding voice quality, self-perception and quality of life in voice. However, vocal therapy with low-frequency TENS followed by vocal exercise was effective in reducing vocal fold lesion size in dysphonic women." @default.
• W4294724274 created "2022-09-06" @default.
• W4294724274 creator A5032679880 @default.
• W4294724274 creator A5043493084 @default.
• W4294724274 creator A5049675743 @default.
• W4294724274 creator A5058961929 @default.
• W4294724274 creator A5076452917 @default.
• W4294724274 date "2022-09-01" @default.
• W4294724274 modified "2023-10-16" @default.
• W4294724274 title "Can Vocal Therapy With Transcutaneous Electrical Nerve Stimulation (TENS) Followed by Vocal Exercises Reduce Benign Laryngeal Lesions in Dysphonic Women?: Randomized, Blind Clinical Trial" @default.
• W4294724274 cites W1434983550 @default.
• W4294724274 cites W1605494380 @default.
• W4294724274 cites W1982976416 @default.
• W4294724274 cites W1983752151 @default.
• W4294724274 cites W2001922257 @default.
• W4294724274 cites W2003042698 @default.
• W4294724274 cites W2005335314 @default.
• W4294724274 cites W2014779151 @default.
• W4294724274 cites W2020343820 @default.
• W4294724274 cites W2028270205 @default.
• W4294724274 cites W2029501088 @default.
• W4294724274 cites W2031048723 @default.
• W4294724274 cites W2032482869 @default.
• W4294724274 cites W2041208408 @default.
• W4294724274 cites W2052143900 @default.
• W4294724274 cites W2052242407 @default.
• W4294724274 cites W2056668157 @default.
• W4294724274 cites W2066833106 @default.
• W4294724274 cites W2079993228 @default.
• W4294724274 cites W2080475448 @default.
• W4294724274 cites W2084356313 @default.
• W4294724274 cites W2098192158 @default.
• W4294724274 cites W2105739011 @default.
• W4294724274 cites W2115679629 @default.
• W4294724274 cites W2125519544 @default.
• W4294724274 cites W2140416375 @default.
• W4294724274 cites W2146073471 @default.
• W4294724274 cites W2147088958 @default.
• W4294724274 cites W2158782719 @default.
• W4294724274 cites W2164777277 @default.
• W4294724274 cites W2171811200 @default.
• W4294724274 cites W2252809633 @default.
• W4294724274 cites W2400291205 @default.
• W4294724274 cites W2402887956 @default.
• W4294724274 cites W252966384 @default.
• W4294724274 cites W2615115246 @default.
• W4294724274 cites W2616533758 @default.
• W4294724274 cites W2790627288 @default.
• W4294724274 cites W2803293606 @default.
• W4294724274 cites W2884313467 @default.
• W4294724274 cites W2944793348 @default.
• W4294724274 cites W2966680613 @default.
• W4294724274 cites W4247903468 @default.
• W4294724274 cites W4251309721 @default.
• W4294724274 doi "https://doi.org/10.1016/j.jvoice.2022.08.006" @default.
• W4294724274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36068131" @default.
• W4294724274 hasPublicationYear "2022" @default.
• W4294724274 type Work @default.
• W4294724274 citedByCount "0" @default.
• W4294724274 crossrefType "journal-article" @default.
• W4294724274 hasAuthorship W4294724274A5032679880 @default.
• W4294724274 hasAuthorship W4294724274A5043493084 @default.
• W4294724274 hasAuthorship W4294724274A5049675743 @default.
• W4294724274 hasAuthorship W4294724274A5058961929 @default.
• W4294724274 hasAuthorship W4294724274A5076452917 @default.
• W4294724274 hasConcept C141071460 @default.
• W4294724274 hasConcept C142724271 @default.
• W4294724274 hasConcept C15744967 @default.
• W4294724274 hasConcept C159110408 @default.
• W4294724274 hasConcept C168563851 @default.
• W4294724274 hasConcept C204787440 @default.
• W4294724274 hasConcept C2779918689 @default.
• W4294724274 hasConcept C2779951463 @default.
• W4294724274 hasConcept C2780009028 @default.
• W4294724274 hasConcept C2780118021 @default.
• W4294724274 hasConcept C2780474809 @default.
• W4294724274 hasConcept C2909265923 @default.
• W4294724274 hasConcept C542102704 @default.
• W4294724274 hasConcept C548259974 @default.
• W4294724274 hasConcept C71924100 @default.
• W4294724274 hasConceptScore W4294724274C141071460 @default.
• W4294724274 hasConceptScore W4294724274C142724271 @default.
• W4294724274 hasConceptScore W4294724274C15744967 @default.
• W4294724274 hasConceptScore W4294724274C159110408 @default.
• W4294724274 hasConceptScore W4294724274C168563851 @default.
• W4294724274 hasConceptScore W4294724274C204787440 @default.
• W4294724274 hasConceptScore W4294724274C2779918689 @default.
• W4294724274 hasConceptScore W4294724274C2779951463 @default.
• W4294724274 hasConceptScore W4294724274C2780009028 @default.
• W4294724274 hasConceptScore W4294724274C2780118021 @default.
• W4294724274 hasConceptScore W4294724274C2780474809 @default.
• W4294724274 hasConceptScore W4294724274C2909265923 @default.
• W4294724274 hasConceptScore W4294724274C542102704 @default.
• W4294724274 hasConceptScore W4294724274C548259974 @default.
• W4294724274 hasConceptScore W4294724274C71924100 @default.
• W4294724274 hasFunder F4320320997 @default.
• W4294724274 hasLocation W42947242741 @default.
• W4294724274 hasLocation W42947242742 @default.
• W4294724274 hasOpenAccess W4294724274 @default.
• W4294724274 hasPrimaryLocation W42947242741 @default.

• next